BR0213488A - Formulação de xarope de epinastina seca e aquosa - Google Patents

Formulação de xarope de epinastina seca e aquosa

Info

Publication number
BR0213488A
BR0213488A BR0213488-8A BR0213488A BR0213488A BR 0213488 A BR0213488 A BR 0213488A BR 0213488 A BR0213488 A BR 0213488A BR 0213488 A BR0213488 A BR 0213488A
Authority
BR
Brazil
Prior art keywords
epinastine
formulation
syrup
dry
pain
Prior art date
Application number
BR0213488-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Koichi Wada
Manabu Nakatani
Toshimitsu Ohki
Kenzo Toyoshima
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0213488A publication Critical patent/BR0213488A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
BR0213488-8A 2001-10-26 2002-10-08 Formulação de xarope de epinastina seca e aquosa BR0213488A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152973A DE10152973A1 (de) 2001-10-26 2001-10-26 Neue trockene und wässrige Epinastin-Sirup-Formulierung
PCT/EP2002/011250 WO2003037350A1 (en) 2001-10-26 2002-10-08 New dry and aqueous epinastine-syrup-formulation

Publications (1)

Publication Number Publication Date
BR0213488A true BR0213488A (pt) 2004-11-03

Family

ID=7703856

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213488-8A BR0213488A (pt) 2001-10-26 2002-10-08 Formulação de xarope de epinastina seca e aquosa

Country Status (9)

Country Link
EP (1) EP1448204A1 (de)
JP (2) JP4564749B2 (de)
KR (1) KR20050034619A (de)
BR (1) BR0213488A (de)
CO (1) CO5580751A2 (de)
DE (1) DE10152973A1 (de)
EC (1) ECSP045087A (de)
MX (1) MXPA04003772A (de)
WO (1) WO2003037350A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452177A1 (de) * 2003-02-27 2004-09-01 Boehringer Ingelheim International GmbH Pharmazeutische Zusammensetzungen welche Natriumlaurylsulfat als Bitterkeits-maskierenden Stoff enthalten
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
WO2005089803A2 (en) * 2004-03-24 2005-09-29 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs
JP5132090B2 (ja) * 2006-06-16 2013-01-30 東和薬品株式会社 塩酸エピナスチンドライシロップ剤
CN105708808B (zh) * 2014-12-01 2018-11-27 重庆安格龙翔医药科技有限公司 一种盐酸依匹斯汀颗粒剂及其制备方法
CN105708840A (zh) * 2014-12-01 2016-06-29 重庆安格龙翔医药科技有限公司 一种盐酸依匹斯汀组合物
CN105708807B (zh) * 2014-12-01 2018-11-27 重庆安格龙翔医药科技有限公司 一种盐酸依匹斯汀细粒剂的制备方法
JP2020172486A (ja) * 2019-04-10 2020-10-22 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
EP0658340A1 (de) * 1993-12-17 1995-06-21 Unilever N.V. Orale Zusammensetzungen
JPH0827034A (ja) * 1994-07-14 1996-01-30 Nikken Chem Co Ltd エリスリトール含有内用液剤
JPH0952849A (ja) * 1995-06-06 1997-02-25 Taisho Pharmaceut Co Ltd 感冒剤用組成物
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
JPH1045576A (ja) * 1996-08-05 1998-02-17 Taisho Pharmaceut Co Ltd 鼻炎用内服薬
AU9187598A (en) * 1997-09-30 1999-04-23 Daiichi Pharmaceutical Co., Ltd. Oral preparation
JPH11302189A (ja) * 1998-04-21 1999-11-02 Taisho Pharmaceut Co Ltd 感冒用組成物
JP4731777B2 (ja) * 1999-10-12 2011-07-27 マルホ株式会社 経口医薬組成物

Also Published As

Publication number Publication date
EP1448204A1 (de) 2004-08-25
JP2010132702A (ja) 2010-06-17
CO5580751A2 (es) 2005-11-30
DE10152973A1 (de) 2003-05-08
JP4564749B2 (ja) 2010-10-20
MXPA04003772A (es) 2004-07-30
KR20050034619A (ko) 2005-04-14
WO2003037350A1 (en) 2003-05-08
ECSP045087A (es) 2004-06-28
JP2005508364A (ja) 2005-03-31

Similar Documents

Publication Publication Date Title
BRPI0911681B8 (pt) composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula in vitro
BR0116097A (pt) Composição de tratamento de tecidos, uso de uma composição, e, método de tratamento de tecidos
GB0504828D0 (en) Therapeutic agents
BR9713770A (pt) Composições detergentes para lavagem de louça contendo alcanolamina
ES2181845T3 (es) Uso de tomoxetina para el tratamiento de la hiperactividad inducida por trastornos de la atencion.
UY27760A1 (es) Nuevos derivados de pirrolidinio.
BR9913512A (pt) Derivados de 4,4-biarilpiperidina com atividade de receptor de opióide
NO20054546L (no) Kinazoliner anvendelige som modulatorer av ionekanaler
BR0213488A (pt) Formulação de xarope de epinastina seca e aquosa
NO20064852L (no) Azaindoler som er nyttige som inhibitorer av jak og andre proteinkinaser
ECSP099662A (es) Nuevos Derivados de 3-([1,2,4]triazolo[4,3-a]piridin-7-il)benzamida
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
BRPI0506970A (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
BRPI0212586B8 (pt) composição na forma de uma solução aquosa, e, uso da mesma
BR9903211A (pt) Composição e utilização de um poliuretano associativo
BRPI0821743B8 (pt) derivados de piridazinona, e seu uso
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
NO20071378L (no) Tiazolo-naftylsyrer.
BR0316296A (pt) Compostos lapacone e seus métodos de uso
BRPI0407253A (pt) Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos
BR0109515A (pt) Derivados da apomorfina e métodos para seu uso
TR200201250T2 (tr) Hidroksieikosatetraenoat tuzları, bileşimleri ve bunların göz kuruması bozukluklarının iyileştirilmesinde kullanım yöntemleri.
BRPI0406596A (pt) Métodos para tratar a dor articular e melhorar o sono utilizando um agonista/antagonista de estrogênio
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
BRPI0409882A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired